Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metformin in lung cancer: rationale for a combination therapy.
Morgillo F, Sasso FC, Della Corte CM, Festino L, Manzo A, Martinelli E, Troiani T, Capuano A, Ciardiello F. Morgillo F, et al. Among authors: sasso fc. Expert Opin Investig Drugs. 2013 Nov;22(11):1401-9. doi: 10.1517/13543784.2013.828691. Epub 2013 Aug 12. Expert Opin Investig Drugs. 2013. PMID: 23937224 Review.
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.
Morgillo F, Sasso FC, Della Corte CM, Vitagliano D, D'Aiuto E, Troiani T, Martinelli E, De Vita F, Orditura M, De Palma R, Ciardiello F. Morgillo F, et al. Among authors: sasso fc. Clin Cancer Res. 2013 Jul 1;19(13):3508-19. doi: 10.1158/1078-0432.CCR-12-2777. Epub 2013 May 21. Clin Cancer Res. 2013. PMID: 23695170
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial.
Fasano M, Della Corte CM, Capuano A, Sasso FC, Papaccio F, Berrino L, Ciardiello F, Morgillo F. Fasano M, et al. Among authors: sasso fc. Clin Lung Cancer. 2015 Jan;16(1):57-9. doi: 10.1016/j.cllc.2014.06.010. Epub 2014 Aug 17. Clin Lung Cancer. 2015. PMID: 25242667 Clinical Trial.
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells.
Della Corte CM, Ciaramella V, Di Mauro C, Castellone MD, Papaccio F, Fasano M, Sasso FC, Martinelli E, Troiani T, De Vita F, Orditura M, Bianco R, Ciardiello F, Morgillo F. Della Corte CM, et al. Among authors: sasso fc. Oncotarget. 2016 Jan 26;7(4):4265-78. doi: 10.18632/oncotarget.6559. Oncotarget. 2016. PMID: 26673006 Free PMC article.
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer.
Morgillo F, Fasano M, Della Corte CM, Sasso FC, Papaccio F, Viscardi G, Esposito G, Di Liello R, Normanno N, Capuano A, Berrino L, Vicidomini G, Fiorelli A, Santini M, Ciardiello F. Morgillo F, et al. Among authors: sasso fc. ESMO Open. 2017 May 2;2(2):e000132. doi: 10.1136/esmoopen-2016-000132. eCollection 2017. ESMO Open. 2017. PMID: 28761738 Free PMC article.
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC.
Ciaramella V, Sasso FC, Di Liello R, Corte CMD, Barra G, Viscardi G, Esposito G, Sparano F, Troiani T, Martinelli E, Orditura M, De Vita F, Ciardiello F, Morgillo F. Ciaramella V, et al. Among authors: sasso fc. J Exp Clin Cancer Res. 2019 Apr 26;38(1):178. doi: 10.1186/s13046-019-1176-1. J Exp Clin Cancer Res. 2019. PMID: 31027492 Free PMC article.
Metformin: An old drug against old age and associated morbidities.
Salvatore T, Pafundi PC, Morgillo F, Di Liello R, Galiero R, Nevola R, Marfella R, Monaco L, Rinaldi L, Adinolfi LE, Sasso FC. Salvatore T, et al. Among authors: sasso fc. Diabetes Res Clin Pract. 2020 Feb;160:108025. doi: 10.1016/j.diabres.2020.108025. Epub 2020 Jan 16. Diabetes Res Clin Pract. 2020. PMID: 31954752 Review.
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.
Rinaldi L, Perrella A, Guarino M, De Luca M, Piai G, Coppola N, Pafundi PC, Ciardiello F, Fasano M, Martinelli E, Valente G, Nevola R, Monari C, Miglioresi L, Guerrera B, Berretta M, Sasso FC, Morisco F, Izzi A, Adinolfi LE. Rinaldi L, et al. Among authors: sasso fc. J Transl Med. 2019 Aug 28;17(1):292. doi: 10.1186/s12967-019-2033-x. J Transl Med. 2019. PMID: 31462268 Free PMC article.
Metformin lactic acidosis: Should we still be afraid?
Salvatore T, Pafundi PC, Marfella R, Sardu C, Rinaldi L, Monaco L, Ricozzi C, Imbriani S, Nevola R, Adinolfi LE, Sasso FC. Salvatore T, et al. Among authors: sasso fc. Diabetes Res Clin Pract. 2019 Nov;157:107879. doi: 10.1016/j.diabres.2019.107879. Epub 2019 Oct 13. Diabetes Res Clin Pract. 2019. PMID: 31618624 Review.
218 results